Pharma & Bio
Technology
GSK Also Bets Up to $1.4 Billion on a New Drug from China… K-Bio Falls Further Behind China
(Graphic: ChatGPT)
GlaxoSmithKline (GSK) is set to begin full-scale Phase 3 clinical trials for a long-acting antibody called “felcorekibart,” which originated in China. This comes approximately t…
Technology
i-SENS, Inc., Once a Money Pit, Takes Off… With Margins in the Mid-40s, Can It Achieve Annual Sales of 40 Billion?
i-SENS, Inc.(099190)’s continuous glucose monitoring (CGM) business has begun to secure profitability following its revenue growth. With CGM sales in the first half of this year surpassing last year’s…
Lifestyle
Skylabs Makes a Strong Debut; Samik Pharma and Penetrium Bio Also Surge [K-Bio Pulse]
As the domestic stock market refocuses on solid corporate performance, clinical developments, and tangible commercialization milestones, the biotech sector saw strong capital inflows on September 4, t…
Lifestyle
SkyLabs Makes Its Mark on First Day of Listing… SAMIK PHARM. Co., LTD. and PenetriumBio Also Rise [Bio Spotlight]
As the domestic securities market has recently been realigning itself around corporate earnings and tangible clinical and commercialization achievements, the biotech sector also saw strong buying inte…
Lifestyle
“Expanding into the Aesthetics Market… Establishing a 90 Billion Won Production System”
“Building on the solid manufacturing infrastructure established through oral care over-the-counter products and the reputation for quality accumulated over the past 20 years, we are now actively expan…
Technology
GC Wellbeing and JW Pharmaceutical Rally [K-bio Pulse]
South Korea’s pharmaceutical and biotech sector experienced significant volatility on August 13, driven by growth themes in obesity/medical aesthetics, hair loss, and immuno-oncology. #GCWellbeing sur…
Technology
[Bio Spotlight] GC WellBeing Soars on Phase 3 Clinical Trial Results for Fat-Dissolving Injection… JW SHINYAK CORPORATION Also Rises
On the 3rd, the domestic pharmaceutical and biotech sector saw notable volatility in stocks linked to growth themes such as obesity, medical aesthetics, hair loss, and immuno-oncology platforms. On th…
Technology
Ildong Pharma Jumps 14% on Patent Ruling, Renewed Hopes for Obesity Drug Licensing [K-Bio Pulse]
Ildong Pharmaceutical stock trend on August 10. (Image: MP Doctor)
On September 2, Ildong Pharmaceutical emerged as one of the strongest performers among South Korean pharmaceutical and biotech st…
Technology
ILDONG PHARM Jumps 14%… Patent Ruling Revives Hopes for Weight-Loss Drug [Bio Spotlight]
Il Dong Pharmaceutical Stock Price Trend. (Source: KG Zeroin MP Doctor)
On the 2nd, ILDONG PHARM(249420)surged in the domestic pharmaceutical and biotech market. This is believed to be due to buyi…
Lifestyle
Genome&Company’s GENA-120: Expectations Rise for Technology Transfer Following Deal with China’s Cestone
Genome&Company(314130)is aiming for its third technology export deal, led by its next-generation antibody-drug conjugate (ADC) candidate, “GENA-120.” Although GENA-120 is still in the early clinical s…